References
- 1. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database // Cancer, 2007; 110:738 - 744
- 2. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors // J Am Coll Surg, 2004; 198:722 -731
- 3. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio- Donahue C, Jimeno A, Gabrielson KL, Matsui W, Maitra A. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers // Cancer Res, 2007; 67:2187 - 2196
- 4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 // Eur J Cancer, 2013; 49:1374 - 1403
- 5. Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knösel T. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma // J Clin Pathol, 2011; 64:990 - 994
- 6. Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas // Br J Cancer, 2011; 104:1296 -1302
- 7. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio- Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses // Science, 2008; 321:1801 - 1806
- 8. Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments // Biomark Med, 2012; 6:597 -612
- 9. Kppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Tumours of the exocrine pancreas // Hamilton SR, Aaltonen LA. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC; 2000; 219 - 230
- 10. Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ. Contribution of epithelial-tomesenchymal transition and cancer stem cells to pancreatic cancer progression // J Surg Res, 2012; 173:105 - 112
- 11. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients // Ann Surg, 2003; 237:74 - 85
- 12. Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF. Hereditary pancreatic cancer // Pancreatology, 2001; 1:466 - 471
- 13. Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis // J Surg Oncol, 2013; 107:8 - 14
- 14. McCleary-Wheeler AL, Lomberk GA, Weiss FU, Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna JL, Ellenrieder V, Urrutia R, Fernandez-Zapico ME. Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis // Cancer Lett, 2013; 328:212 - 221
- 15. Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer // Minerva Gastroenterol Dietol, 2012; 58:283 - 297
- 16. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer // Cancer, 1995; 76:1671 - 1677
- 17. Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer // Ann Surg, 2013; 258:336 - 346
- 18. Pannala R, Basu A, Petersen GM, Chari ST. Newonset diabetes: a potential clue to the early diagnosis of pancreatic cancer // Lancet Oncol, 2009; 10:88 -95
- 19. Pavai S, Yap SF. The clinical significance of elevated levels of serum CA 19-9 // Med J Malaysia, 2003; 58:667 - 672
- 20. Poi MJ, Knobloch TJ, Yuan C, Tsai MD, Weghorst CM, Li J. Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis // Biochem Biophys Res Commun, 2013, 436:217 - 222
- 21. Rohan VS, Hsu JT, Liu KH, Yeh CN, Yeh TS, Jan YY, Hwang TL. Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas // J Gastrointest Cancer, 2013; 44:89 - 93
- 22. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T, Cameron JL, Yeo CJ, Hruban RH, Goggins M. p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis // Am J Surg Pathol, 2003; 27:1495 -1501
- 23. Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia // Mod Pathol, 2008; 21:238 - 244
- 24. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumorsuppressive pathway in virtually all pancreatic carcinomas // Cancer Res, 1997; 57:3126 - 3130
- 25. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 // CA Cancer J Clin, 2012; 62:10 - 29
- 26. Simtniece Z, Strumfa I, Abolins A, Vanags A, Gardovskis J. Prognostic factors after curative resection of pancreatic ductal adenocarcinoma: a retrospective study // Journal of Cancer Therapeutics & Research, 2012; 1:http://www. hoajonline.com/jctr/2049-7962/1/27#
- 27. Takaori K, Hruban RH, Maitra A, Tanigawa N. Current topics on precursors to pancreatic cancer // Adv Med Sci, 2006; 51:23 - 30
- 28. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernándezdel Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis // Nature, 2003; 425:851 - 856
- 29. Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: an overview // J Gastrointest Oncol, 2011; 2:168 - 174
- 30. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer // Gastroenterology, 2013; 144:1252 - 1261